The historical rank and industry rank for Enorama Pharma AB's OCF Margin % or its related term are showing as below:
OSTO:ERMA'
s OCF Margin % Range Over the Past 10 Years
Min: -3044.85 Med: -423.84 Max: -226.42
Current: -2113.11
During the past 12 years, the highest OCF Margin % of Enorama Pharma AB was -226.42%. The lowest was -3044.85%. And the median was -423.84%.
OSTO:ERMA's OCF Margin % is ranked worse than 97.49% of 956
companies
in the Drug Manufacturers industry
Industry Median: 9.985
vs OSTO:ERMA: -2113.11
Enorama Pharma AB OCF Margin % Related Terms
Enorama Pharma AB OCF Margin % Historical Data
* Premium members only.
The historical data trend for Enorama Pharma AB's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ERMA vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Enorama Pharma AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enorama Pharma AB OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Enorama Pharma AB's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Enorama Pharma AB's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enorama Pharma AB (OSTO:ERMA) has a OCF Margin % of 11,088.99% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Enorama Pharma AB and its competitors. According to the industry distribution chart, Enorama Pharma AB ranks #932 out of 956 companies in the Drug Manufacturers industry, placing it in the top 97.5%.
Is Enorama Pharma AB's OCF Margin % too high?
Enorama Pharma AB's current OCF Margin % is 11,088.99%. The Drug Manufacturers industry median OCF Margin % is 9.99. Enorama Pharma AB's value of 11,088.99% is 110956.5% above this industry median. Based on the distribution chart, Enorama Pharma AB ranks #932 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Enorama Pharma AB has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Enorama Pharma AB's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Enorama Pharma AB ranks #932 out of 956 companies for OCF Margin %. This places Enorama Pharma AB in the lower half of its industry. The industry median OCF Margin % is 9.99. Enorama Pharma AB's value of 11,088.99% is 110956.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Enorama Pharma AB's current OCF Margin % of 11,088.99% is 110956.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Enorama Pharma AB and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Enorama Pharma AB's current OCF Margin % is 11,088.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enorama Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, Enorama Pharma AB (OSTO:ERMA) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.42, compared to a current price of kr0.26 — trading 39.3% below its estimated fair value. The current OCF Margin % is 11,088.99% and 110956.5% above the Drug Manufacturers industry median of 9.99. Enorama Pharma AB's overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Enorama Pharma AB (OSTO:ERMA), the current OCF Margin % is 11,088.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Enorama Pharma AB (OSTO:ERMA) Overvalued in 2026?
Based on GuruFocus' analysis, Enorama Pharma AB stock appears to be undervalued.
The current stock price of kr0.26 is trading 39.3% below its estimated GF Value™ of kr0.42.
GuruFocus considers Enorama Pharma AB to be Possible Value Trap.
Key valuation signals for OSTO:ERMA:
OCF Margin %: 11,088.99%
GF Value™: kr0.42 vs. price of kr0.26 (39.3% below fair value)
Industry Position: 110956.5% above the Drug Manufacturers median (#932 of 956)
No single metric tells the full story. See the OSTO:ERMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Enorama Pharma AB is a pharmaceutical company that focuses on consumer-friendly medicated chewing gum containing generic substances. It provides medicated gums containing generic pharmaceutical substances, developed through its ChewMed technology platform.
28GF Score
Get the complete analysis for OSTO:ERMA
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ERMA has been successfully added to your 
